Kelly Lightfoot represents a variety of participants in the regenerative medicine industry, both public and private, including biologics manufacturers, clinical trial sponsors, medical device manufacturers, cryogenic banking facilities, medical tourism businesses, and physicians engaged in the development of autologous stem cell therapies.